Foxp3 confers long-term efficacy of chimeric antigen receptor-T cells via metabolic reprogramming
Congyi Niu(Suzhou Institute of Systems Medicine), Feifei Luo(Jiangxi University of Traditional Chinese Medicine), Wanwei Zheng(Fudan University), Luman Wang(Fudan University), Yiwei Chu(Fudan University), Yiyuan Gao(Shanghai Medical College of Fudan University), Jingbo Qie(Fudan University), Shaocong Mo(Fudan University), Yuedi Wang(Fudan University), Ronghua Liu(China Institute of Water Resources and Hydropower Research), Congwen Li(Shanghai Medical College of Fudan University), Huan Song(Fudan University), Jie Liu(The Ohio State University), Dan Zhang(Shanghai Medical College of Fudan University), Xuanxuan Pan(Fudan University), Zixin Lv(Shanghai Medical College of Fudan University), Huan Wei(Shanghai Medical College of Fudan University), Wenwei Tu(University of Hong Kong), Kameina Zhuma(Shanghai Medical College of Fudan University), Jiawen Qian(Fudan University)
Cited by 35
Related Papers
SIRT5 Desuccinylates and Activates Pyruvate Kinase M2 to Block Macrophage IL-1β Production and to Prevent DSS-Induced Colitis in Mice
|Cell Reports|2017|340
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
|Journal of Neuroinflammation|2018|264
Lipid metabolism in inflammation-related diseases
|The Analyst|2018|183
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
|Journal of Hematology & Oncology|2020|183
TLR2 Promotes Glioma Immune Evasion by Downregulating MHC Class II Molecules in Microglia
|Cancer Immunology Research|2018|137